CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France.
CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM U12-11, Laboratoire de Maladies Rares: Génétique et Métabolisme (MRGM), 176 Rue Léo Saignat, F-33000 Bordeaux, France.
J Clin Anesth. 2021 Dec;75:110435. doi: 10.1016/j.jclinane.2021.110435. Epub 2021 Jul 22.
Our objective was to develop a clinical scale (the VENSCORE) to predict pre-operative peripheral intravenous cannula (PIVC) insertion failure at the first attempt in adults.
This was a prospective multicenter cohort study that included internal validation with bootstrapping.
The operating rooms of 14 hospitals in southern France from June 2016 to June 2018.
Consecutive adult patients aged 18 years or older were recruited upon arrival to the operating room, regardless of American Society of Anaesthesiology (ASA) physical status.
PIVC insertion on arrival to the OR.
PIVC insertion failure at the first attempt was the outcome of interest. Data collected included the number of PIVC insertion attempts and potential predictors of the risk of failure (including pre-operative patient characteristics and data relative to the procedure). Uni- and multivariable logistic analyses were performed. Based on these results, the VENSCORE scale was developed to predict the risk of failure of the first PIVC insertion.
In total, 3394 patients were included, and 27 were excluded because of protocol violations. The PIVC insertion failure rate at the first attempt was 20.3%. Based on multivariable analysis, a history of difficult PIVC insertions, high-risk surgery, poor vein visibility, and moderate to poor vein palpability were identified as risk factors for insertion failure at the first attempt. The area under the curve of the predictive model was 0.82 (95% confidence interval: 0.80-0.84). A VENSCORE value of 0 points was associated with a failure rate of 7%, versus 97% for a score of 6.
The four-item VENSCORE scale could be useful for prospectively identifying adults at risk of first PIVC insertion attempt failure.
我们旨在开发一种临床量表(VENSCore),以预测成人首次外周静脉穿刺(PIVC)置管的术前失败。
这是一项前瞻性多中心队列研究,包括使用自举法进行内部验证。
2016 年 6 月至 2018 年 6 月,法国南部 14 家医院的手术室。
连续纳入成年患者,年龄 18 岁或以上,无论美国麻醉医师协会(ASA)身体状况如何,均在到达手术室时入组。
到达手术室时进行 PIVC 置管。
首次尝试时 PIVC 置管失败是感兴趣的结局。收集的数据包括 PIVC 置管尝试次数和失败风险的潜在预测因素(包括术前患者特征和与手术相关的数据)。进行单变量和多变量逻辑分析。基于这些结果,开发了 VENSCORE 量表,以预测首次 PIVC 插入失败的风险。
共纳入 3394 例患者,因违反方案 27 例被排除。首次尝试时 PIVC 置管失败率为 20.3%。基于多变量分析,既往 PIVC 置管困难、高危手术、静脉可视性差以及中等至差静脉触诊被确定为首次尝试置管失败的危险因素。预测模型的曲线下面积为 0.82(95%置信区间:0.80-0.84)。VENSCore 值为 0 分与失败率为 7%相关,而 6 分与失败率为 97%相关。
四项 VENSCORE 量表可用于前瞻性识别首次 PIVC 置管尝试失败风险的成人。